Posted by Michael Wonder on 08 Apr 2026
Menopausal women with a low sex drive won’t have cheaper access to drug
8 April 2026 - Australia’s medicines subsidy gatekeeper has rejected cheaper access to a testosterone product for women. Some are questioning whether that’s fair.
About one in five women who reach menopause lists a loss of libido, or sex drive, as a symptom, along with difficulties with sex. So is Australia’s medicines gatekeeper acting in women’s best interests by restricting subsidised access to one of the few treatments available?
